Respiro Diagnostics raises $1.27M pre seed
Respiro Diagnostics raised $1.27M in pre seed funding, announced on 8 July 2026, led by Zinc Venture Capital, SFC Capital, with participation from Amadeus Capital Partners, Conception X Angel Syndicate, KQ Labs, Francis Crick Institute, Innovate UK. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
UK-based startup developing breath-based diagnostics for lung diseases using non-invasive liquid biopsy technology. Respiro Diagnostics is based in United Kingdom and currently at pre seed stage, operating in healthtech, deeptech.
Round details
| Company | Respiro Diagnostics |
| Stage | pre seed |
| Amount | $1.27M |
| Announced | 8 July 2026 |
| Lead | Zinc Venture Capital, SFC Capital |
| Participation | Amadeus Capital Partners, Conception X Angel Syndicate, KQ Labs, Francis Crick Institute, Innovate UK |
| Source | announcement ↗ |
Explore: Pre-Seed · United Kingdom
Frequently asked questions
- How much did Respiro Diagnostics raise?
- Respiro Diagnostics raised $1.3M in its pre-seed round, announced 2026-07-08.
- Who invested in Respiro Diagnostics's pre-seed round?
- The round was led by Zinc Venture Capital and SFC Capital, with participation from Amadeus Capital Partners, Conception X Angel Syndicate, KQ Labs, Francis Crick Institute and Innovate UK.
- What does Respiro Diagnostics do?
- UK-based startup developing breath-based diagnostics for lung diseases using non-invasive liquid biopsy technology.
Verified 8 July 2026 · Sources: public filings